Fig. 4
From: The expression and survival significance of sodium glucose transporters in pancreatic cancer
Correlation between SGLT-1 (SLC5A1) and prognosis of PDAC patients in stage I and II. A and B Kaplan-Meier analysis of OS for stage I and II patients with high vs. low SGLT-1 expression in IHC. C Kaplan-Meier analysis of OS for stage I and II patients with high vs. low SGLT-1 (SLC5A1) mRNA expression based on data downloaded from TCGA. D Kaplan–Meier analysis of PFS for stage I and II patients with high vs. low SGLT-1 (SLC5A1) mRNA expression based on data downloaded from TCGA. (* for P < 0.05, ** for P < 0.01)